Industry Focus Articles
U.S. ports play a major role in the many advantages Foreign Trade Zones offer. This one-two punch keeps America competitive in the race for investment dollars and helps power the recovery.
The U.S. lead in biotechnology no longer is a sure thing as growth leaders like China and India join the fray. Government, industry and academia must join forces to remain No. 1.
In a shaky recovery, one thing is certain—the steady increase in alternative energy projects will continue to power jobs growth across the nation into the foreseeable future.
Home healthcare products—including therapeutic devices, monitors, sensors and telemetry devices—are expected to be one of the fastest-growing segments of the medical device industry.
In a challenging economic environment, an efficient logistics and distribution network is moving to the top of the list of requirements for business growth and expansion.
The biotechnology industry is poised to address some of the world’s most pressing challenges, and it continues to outperform annual growth in private-sector employment.
With cloud computing infringing on the need for bricks and mortar and the Feds consolidating, the competition for data center projects has intensified.
Bioscience and pharma labs are not just incubators for new drugs and technology—they are building blocks for job growth.
As the economy slowly rebounds, businesses will need to restructure their distribution networks to maximize efficiency and minimize miles to capitalize on the recovery when it occurs.
Locations across the country have made renewable energy central to their economic recovery strategies. The race is on to claim a leadership position in solar, wind, geothermal and biofuel generation and manufacturing.